Moderna (MRNA) reached a 10-year agreement with Swiss biotechnology company Lonza aimed at making up to 1 billion doses a year of a vaccine to combat the coronavirus.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,